Search the 9 jobs at NLC Health Ventures

The CEO will lead PelviSure in developing advanced treatment for stress urinary incontinence, overseeing product development, fundraising, and regulatory approvals, while building strategic partnerships and engaging with healthcare professionals and patient communities.

As CEO of Venous Stent, you will lead the transition of a novel venous stent from clinical validation to market success. Responsibilities include regulatory oversight, financial leadership, strategic corporate outreach, clinical support, and team management, with a focus on improving patient outcomes in cardiovascular care.

This job is an application process for candidates interested in future opportunities with NLC. Candidates can submit their CV to join a pool for consideration in upcoming vacancies.

As CEO of ArtiFex, you'll lead the development and clinical validation of a revolutionary artificial vascular graft, drive fundraising efforts for clinical trials, and cultivate strategic partnerships and stakeholder relationships. You'll also work closely with cardiovascular surgeons to ensure clinical relevance and develop strategies for a successful exit, all while leveraging your extensive network in the cardiovascular medical device industry.

As CEO, you will develop and implement strategies for growth and innovation in allergy diagnostics, oversee operations and compliance, drive fundraising, and collaborate with medical partners. Your goal is to position VisDX as a leader in accessible and effective allergy testing.

As CEO, you will lead miRisten in advancing its innovative leukemia treatments by securing funding, building partnerships, and guiding the company through clinical trials to improve patient outcomes.

The CEO will lead CymiraBio in developing novel therapeutics targeting cancer stem cells. Responsibilities include securing funding, overseeing preclinical research, building strategic partnerships, and guiding the company towards Phase I clinical trials, all while aligning with oncology trends.

The CEO will be responsible for leading the business strategy and execution at LipidEra Therapeutics, focusing on fundraising for biotech assets, developing patent and commercial strategies, and building a network in the cardiometabolic space.

The Biotech Senior Associate / Investment Manager at NLC will lead investment processes, coordinate financial due diligence, craft innovative deal structures, and build relationships with co-investors. Responsibilities include supporting biotech ventures, conducting market research, preparing financial analyses, and staying updated on market dynamics within the healthtech sector.